SCHEMBL30305641

SCHEMBL30305641

CC(C)[C@H](N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C)C(C)C

nearest known ligand 0.53

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MAGI3 Q5TCQ9 1/20 0.53
▸ IL23R Q5VWK5 10/20 0.51
▸ KISS1R Q969F8 3/20 0.51
▸ CTSC P53634 1/20 0.50
▸ SIRT5 Q9NXA8 1/20 0.48
▸ GHSR Q92847 1/20 0.48
▸ CTSB P07858 1/20 0.48
▸ CTSK P43235 1/20 0.48
▸ ACE P12821 1/20 0.48
▸ MC4R P32245 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30945413 1.00 MAGI3 (0.53) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL30148436 1.00 MAGI3 (0.53) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL31065007 0.98 MAGI3 (0.52) MAGI3IL23RKISS1RCTSCGHSR
SCHEMBL30093039 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL30093123 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL30339793 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL30302924 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL30302936 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL29799990 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5
SCHEMBL30305362 0.97 IL23R (0.51) MAGI3IL23RKISS1RCTSCSIRT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4401752-A1 ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF Peptilogics, Inc. (US) 2024-07-24 — — EP claimed
WO-2023044423-A1 ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF PEPTILOGICS, INC. (US) 2023-03-23 — — WO claimed
EP-4401754-A1 ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF Peptilogics, Inc. (US) 2024-07-24 — — EP disclosed
WO-2023044339-A1 ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF PEPTILOGICS, INC. (US) 2023-03-23 — — WO disclosed
Send feedback